Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.35 | N/A |
PEG Ratio (TTM) | -0.01 | N/A |
P/S Ratio (TTM) | 0.12 | N/A |
P/B Ratio (TTM) | 210.96 | N/A |
P/FCF Ratio (TTM) | -0.50 | N/A |
Price to 5YR AVG Earnings Ratio | 0.00 | N/A |
Price to 5YR AVG FCF Ratio | -0.19 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -49.18% | N/A |
ROE (TTM) | -625.11% | N/A |
Net Profit Margin (TTM) | -93.87% | N/A |
ROIC 5YR AVG | -190.06% | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -49.00% | -83.38% | -15.94% |
Revenue | -4.83% | 32.59% | 37.75% |
Net Income | -75.28% | -103.67% | -59.45% |
Cash Flow | -55.96% | -178.59% | -93.40% |
Health (12%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.29 | N/A |
Quick Ratio (TTM) | 0.06 | N/A |
D/E Ratio (TTM) | 405.56 | N/A |
Interest Coverage (TTM) | -2.60 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.02 | N/A |
Shares Outstanding Growth 5YR AVG | 358.83% | N/A |